Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
TURIN, Italy, June 02, 2023 (GLOBE NEWSWIRE) -- ‘From the illusion of abundance to the economy of having enough’. It is the title of the report edited by the Einaudi Center of International Studies...
-
(2023-06-02) Kitron ASA inKitron ASA - Initiation of a share buybackitiates a share buyback Kitron ASA ("Kitron" or the "Company") has decided to initiate a buyback of up to 22 000 of its own shares...
-
(2023-06-02) Kitron ASA initiates a share buyback Kitron ASA ("Kitron" or the "Company") has decided to initiate a buyback of up to 22 000 of its own shares for a total maximum amount of NOK 1 000...
-
Dublin, June 02, 2023 (GLOBE NEWSWIRE) -- The "Global Market for Hydrogen Fuel Cell Passenger Vehicles, 2023" report has been added to ResearchAndMarkets.com's offering. The study provides...
-
VANCOUVER, British Columbia, Kanada, June 02, 2023 (GLOBE NEWSWIRE) -- Monument Mining Limited (TSX-V: MMY und FSE: D7Q1), „Monument“ oder das „Unternehmen“, hat heute seine Produktions- und...
-
VANCOUVER, Colombie-Britannique, 02 juin 2023 (GLOBE NEWSWIRE) -- Monument Mining Limited (TSX-V : MMY et FSE : D7Q1) (« Monument » ou la « Société ») a annoncé aujourd'hui ses résultats de...
-
Dublin, June 02, 2023 (GLOBE NEWSWIRE) -- The "Asia-Pacific Electric Vehicle Battery Swapping Market - By Service Type (Subscription Model and Pay-Per-Use Model), By Vehicle Type (Two-Wheeler,...
-
Peter Caldini to step down following execution of Company turnaround and strong progress against planned business combination under Canopy USA Dennis Curran, Chief Operating Officer of Acreage, has...
-
Decision follows extensive due diligence, as well as careful evaluation of projections and market conditions Progressing with alternative M&A transactions which are expected to be highly...
-
BOSTON, June 02, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and...